Surrozen Presented Data Supporting Potential of SZN-1326 at the 2021 United European Gastroenterology Week
October 5, 2021
Mr. Jeff Goater joins The Column Group as Venture Partner
The Column Group announces the hiring of Mr. Jeff Goater. Previously, Mr. Goater served as Chief Executive Officer of Surface Oncology. Prior to Surface, he served as Chief Financial Officer of Voyager Therapeutics where he was one of the members of the founding management team.
Mr. Jeff Goater joins The Column Group as Venture Partner Read More »
Dr. Sarah Gillmor Hymowitz joins The Column Group as Venture Partner
The Column Group announces the hiring of Dr. Sarah Gillmor Hymowitz. Previously, Dr. Hymowitz spent 22 years at Genentech rising to Vice President of Protein Sciences. In this role, she oversaw the large molecule drug discovery portfolio and mentored project teams on the identification and optimization of more than 35 clinical candidates.
Dr. Sarah Gillmor Hymowitz joins The Column Group as Venture Partner Read More »
TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow
Widely considered to be the father of the biotechnology industry, Robert Swanson changed the world when he founded Genentech with Herbert Boyer in 1976. TCG’s new fellowship program pays homage to Robert Swanson’s legacy, empowering the next generation of young visionaries on their quest to better the world through science and medicine. The Column Group
TCG Launches the Swanson Fellowship Program and Dr. Tobias Schmid joins as first Fellow Read More »